Delving into the Latest Updates on Lavipharm SA with Synapse

Overview

Tags

Nervous System Diseases

Eye Diseases

Cardiovascular Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

ADRA2(Adrenergic receptors alpha-2)	1

The objective of this presentation is to overview recent developments in supercritical fluid processing technologies (SCF) for colloidal drug delivery systems and discuss formulation strategies for liposome, microemulsion, nanoparticle and dry powder inhalation systems using this technol.Supercritical fluid processing is a cutting-edge clean technol. that can be processed with active materials or a mixture of excipients and drugs.SCF processing has the potential to benefit the formulation of biomaterials including proteins, peptides and gene materials, as compared to the conventional methods of spray drying and lyophilization.Several SCF processes exist including rapid expansion of supercritical solutions (RESS), supercritical antisolvent (SAS) and gas antisolvent (GAS).Major considerations for particle formulation include the selection of the supercritical fluid process, solubility of excipients and active materials, solvent selection and particle stability.Particle size, particle morphol., and therapeutic drug activity are used to characterize the formulations.

STP Pharma Sciences

Supercritical fluids applications in the pharmaceutical industry

Author: Perrut, M.

A review.A detailed literature and patent review on recent development of supercritical fluids applications in the pharmaceutical industry is presented: extraction from solids, mainly from natural raw materials, fractionation of liquids and preparative chromatog. for highly-selective separations and active substances purification, reactions in supercritical media for selectivity and kinetics improvement, particle design leading to innovative formulations in order to increase the drug bioactivity and bioavailability, to design controlled-release systems and to replace parenteral drug delivery by less invasive routes (pulmonary, transdermal, oral).Basic guidelines are proposed in order to help the scientists in choosing the optimal process and technol., especially for drug formulation where numerous processes are presently proposed.

Pharmaceutical Research

Transdermal Drug Delivery. Second Edition, edited by Richard H. Guy and Jonathan Hadgraft

Author: Osborne, James

100 Deals associated with Lavipharm SA

Login to view more data

100 Translational Medicine associated with Lavipharm SA

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Jul 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data